ATRenew Sees Q3 Sales $934.400M-$949.139M vs $976.930M Est

Benzinga Newsdesk www.benzinga.com Positive 75.1%

Neg 0% Neu 0% Pos 75.1%

ATRenew (NYSE:RERE) sees Q3 sales of $934.400 million-$949.139 million vs $976.930 million analyst estimate.

Comments

No comments yet. Be the first!